Crossmark

PPP2R2A prostate cancer haploinsufficiency is associated with worse prognosis and a high vulnerability to B55α/PP2A reconstitution that triggers centrosome destabilization

Crossref DOI link: https://doi.org/10.1038/s41389-019-0180-9

Published Online: 2019-12-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhao, Ziran

Kurimchak, Alison

Nikonova, Anna S.

Feiser, Felicity

Wasserman, Jason S.

Fowle, Holly

Varughese, Tinsa

Connors, Megan

Johnson, Katherine

Makhov, Petr

Lindskog, Cecilia

Kolenko, Vladimir M.

Golemis, Erica A. https://orcid.org/0000-0003-3618-3673
Duncan, James S.

Graña, Xavier https://orcid.org/0000-0001-7134-0473
Funding

Funding for this research was provided by:

U.S. Department of Health & Human Services | NIH | National Cancer Institute (U54 CA221704)

U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK108195)
License Information

Text and Data Mining valid from 2019-12-10

Version of Record valid from 2019-12-10
More Information

Article History

Received: 9 September 2019

Revised: 18 November 2019

Accepted: 20 November 2019

First Online: 10 December 2019

Conflict of interest

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below